Schizophrenia Daily News Blog

Microarray to Improve Drug Treatments

Affymetrix, Inc recently released the world's first clinical diagnostic microarray system, the GeneChip System 3000Dx.

Development partners (such as Roche Diagnostics) partner with Affymetrix for the right to use their microarrays and tools. The company then develops genomic diagnostic tests.

For example, with the Roche AmpliChip CYP450 Test, scientists can analyze variations in certain genes that affect the metabolizing rate of common drugs used to treat schizophrenia, depression, bipolar, cardiovascular disease, and others. Having this knowledge will help physicians choose proper drugs and dosages for different patients.

For the full article, see "World's First Diagnostic Microarry System Launched by Affymetrix in European Union" (Sept 1 2004). Web address: http://biz.yahoo.com/prnews/040901/sfw002_1.html